Moretti August J 4
4 · 4D Molecular Therapeutics, Inc. · Filed Dec 22, 2022
Insider Transaction Report
Form 4
Moretti August J
See Remarks
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2022-12-21−3,000→ 220,060 totalExercise: $9.41Exp: 2029-03-19→ Common Stock (3,000 underlying) - Exercise/Conversion
Common Stock
2022-12-21$9.41/sh+3,000$28,230→ 6,595 total
Footnotes (2)
- [F1]Reflects 1,595 shares of the Issuer's common stock purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt from Rule 16b-3.
- [F2]25% of the shares subject to the option vest on the first anniversary measured from January 7, 2019 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.